APA (7th ed.) Citation

Pitts, E. G., Curry, D. W., Hampshire, K. N., Young, M. B., & Howell, L. L. (2018). (±)-MDMA and its enantiomers: Potential therapeutic advantages of <italic>R</italic>(−)-MDMA. Psychopharmacology, 235(2), 377. https://doi.org/10.1007/s00213-017-4812-5

Chicago Style (17th ed.) Citation

Pitts, Elizabeth G., Daniel W. Curry, Karly N. Hampshire, Matthew B. Young, and Leonard L. Howell. "(±)-MDMA and Its Enantiomers: Potential Therapeutic Advantages of R(−)-MDMA." Psychopharmacology 235, no. 2 (2018): 377. https://doi.org/10.1007/s00213-017-4812-5.

MLA (9th ed.) Citation

Pitts, Elizabeth G., et al. "(±)-MDMA and Its Enantiomers: Potential Therapeutic Advantages of R(−)-MDMA." Psychopharmacology, vol. 235, no. 2, 2018, p. 377, https://doi.org/10.1007/s00213-017-4812-5.